Axtria, a leading AI-first data analytics and cloud software provider for the global life sciences industry, has completed a $240 million strategic transaction with India-based private equity firm Kedaara Capital.
The deal includes a secondary investment and company-sponsored share buyback, making it one of the industry’s largest employee-centric liquidity events.
The transaction will provide liquidity to Axtria’s current and former employees, as well as early investors who supported its vision from inception.
“Axtria is transforming life sciences with Agentic AI, but equally important is recognizing the people who built this company,” said Jaswinder Chadha, President & CEO of Axtria.
“Offering liquidity to employees and early backers demonstrates our commitment to long-term value creation. In Kedaara, we’ve found a growth-focused partner who shares our ethos," he added.
Sunish Sharma, Founder and Managing Partner at Kedaara Capital, emphasized their confidence in Axtria’s growth potential: “We are delighted to back Axtria’s talented team as they scale globally and continue to help life sciences companies harness technology and Agentic AI.”
Aashwit Mahajan, Director at Kedaara, added that Axtria’s technological expertise and innovation distinguish it in the market: “We look forward to supporting Axtria’s organic and inorganic expansion.”
Founded in 2010, Axtria supports 18 of the world’s top 20 pharmaceutical companies and over 100 clients in 75+ countries. Its AI-powered platforms: SalesIQ, CustomerIQ, MarketingIQ, DataMAx, and InsightsMAx.ai, help firms move from experimentation to scaled AI deployment, driving efficiency and innovation across the life sciences value chain.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
